We confirmed that the IL-6 signaling dependency did not rely on IL-6 trans-signaling, as blocking IL-6 trans-signaling in sgp130 hosts did not alter tumor growth compared to IL-6 trans-signaling-proficient WT hosts (Figure 4H). This evidence concerns the gene IL6 and neoplasm.